SEC Form 4 · accession 0001156375-18-000134
CME GROUP INC. · CME
Statement of changes in beneficial ownership, as filed. Original on EDGAR ↗
Reporting owner
Charles P Carey
Director
Period of report
Nov 20, 2018
Accepted (ET)
Nov 23, 2018 · 9:58 am EST
Rule 10b5-1 plan
unknown — predates the checkbox
Issuer CIK
0001156375
Table I — non-derivative securities
| Security | Date | Code | Shares | Price | A/D | Owned after | D/I | Nature of ownership |
|---|---|---|---|---|---|---|---|---|
| Common Stock Class AF1 | Nov 20, 2018 | S | 3,000 | $191.64 | D | 26,141 | I | by Firm |
| Common Stock Class AF2 | Nov 21, 2018 | S | 2,000 | $192.15 | D | 24,141 | I | by Firm |
| Common Stock Class A | holding | — | — | — | 1,532 | I | by Trust |
Table II — derivative securities
No Table II lines on this filing.
Explanation of responses
- F1On November 20, 2018, Mr. Carey sold an aggregate of 3,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices with a $1 range have been aggregated and the weighted average has been reported. The price range was $191.04 to $191.90. The Company maintains a record of the transactions and copies will be provided upon request.
- F2On November 21, 2018, Mr. Carey sold an aggregate of 2,000 shares of CME Group Class A common stock. For reporting purposes, the sale prices with a $1 range have been aggregated and the weighted average has been reported. The price range was $191.85 to $192.44. The Company maintains a record of the transactions and copies will be provided upon request.